BOT 4.35% 36.0¢ botanix pharmaceuticals ltd

Ann: FDA Letter Requires Patient Instruction Update, page-114

  1. 12,063 Posts.
    lightbulb Created with Sketch. 6166
    I agree , the only risk to FDA Approval is Managements ability to remedy the situation they have put the company in now..

    Poor would be my grading at present , would have been simple to run the instructions past an agency in the States that prepares FDA Applications as their core business...NZT
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
36.0¢
Change
0.015(4.35%)
Mkt cap ! $642.5M
Open High Low Value Volume
34.5¢ 36.5¢ 34.5¢ $718.2K 2.016M

Buyers (Bids)

No. Vol. Price($)
4 28780 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 218783 7
View Market Depth
Last trade - 11.07am 22/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.